Sandbox:Affan: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
{| class="wikitable"
{| class="wikitable"
|+
|+
! colspan="6" style="background:#4479BA; color: #FFFFFF;" align="center" + |Surface oral lesions
! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Surface oral lesions
|-
|-
! colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Oral lesions
! colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Oral lesions
Line 11: Line 11:
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location
!Microscopic
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image
|-
|-
Line 22: Line 23:
|
|
* Buccal and labial oral mucosa
* Buccal and labial oral mucosa
|
* Intracellular edema or vacuolization of Malpighian cells
|
|
|-
|-
Line 33: Line 36:
* Buccal mucosa
* Buccal mucosa
* Vermillion border of the lips
* Vermillion border of the lips
|
* Similar to normal sebaceous glands of skin
* Lacks hair follicles and almost always lack ductal communication with surface
|
|
|-
|-
Line 46: Line 52:
|
|
* Dorsal/Lateral surface of the tongue
* Dorsal/Lateral surface of the tongue
|
|
|
|-
|-
Line 59: Line 66:
|
|
* Dorsum of the tongue  
* Dorsum of the tongue  
|
|
|
|-
|-
Line 75: Line 83:
* Floor of the mouth
* Floor of the mouth
* Palate
* Palate
|
|
|
|-
|-
Line 86: Line 95:
|
|
* Buccal mucosa
* Buccal mucosa
|
|
|
|-
|-
Line 97: Line 107:
* Posterior buccal mucosa
* Posterior buccal mucosa
* Gingival margin
* Gingival margin
|
|
|
|-
|-
Line 109: Line 120:
* Buccal mucosa
* Buccal mucosa
* Limited to line of dental occlusion
* Limited to line of dental occlusion
|
|
|
|-
|-
Line 120: Line 132:
* Smoking
* Smoking
*  
*  
|
|
|
|
|
Line 133: Line 146:
* Floor of mouth
* Floor of mouth
* Ventral surface of tongue and the retromolar area  
* Ventral surface of tongue and the retromolar area  
|
|
|
|-
|-
Line 139: Line 153:
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions  
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions  
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location
!
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Physiologic pigmentation
* Physiologic pigmentation
|
|
|
|
|
Line 151: Line 167:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Ephelis
* Ephelis
|
|
|
|
|
Line 159: Line 176:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Oral melanocytic macule
* Oral melanocytic macule
|
|
|
|
|
Line 167: Line 185:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Melanocytic nevus
* Melanocytic nevus
|
|
|
|
|
Line 175: Line 194:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Oral melanoacanthoma
* Oral melanoacanthoma
|
|
|
|
|
Line 183: Line 203:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Smoker's melanosis
* Smoker's melanosis
|
|
|
|
|
Line 191: Line 212:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Melanoma
* Melanoma
|
|
|
|
|
Line 199: Line 221:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Kaposi sarcoma
* Kaposi sarcoma
|
|
|
|
|
Line 207: Line 230:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Addison's disease
* Addison's disease
|
|
|
|
|
Line 215: Line 239:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Peutz jeghers syndrome
* Peutz jeghers syndrome
|
|
|
|
|
Line 223: Line 248:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Neurofibromatosis
* Neurofibromatosis
|
|
|
|
|
Line 232: Line 258:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Polyostotic fibrous dysplasia
* Polyostotic fibrous dysplasia
|
|
|
|
|
Line 240: Line 267:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Medication induced pigmentation
* Medication induced pigmentation
|
|
|
|
|
Line 248: Line 276:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
* Amalgam tattoo
* Amalgam tattoo
|
|
|
|
|
Line 258: Line 287:
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |characterestic features
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |characterestic features
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions  
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions  
!
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image
|-
|-
| rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Infections]]
| rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Infections]]
|
|
|
|
|
Line 268: Line 299:
|
|
|-
|-
|
|
|
|
|
Line 274: Line 306:
|
|
|-
|-
|
|
|
|
|
Line 280: Line 313:
|
|
|-
|-
|
|
|
|
|
Line 286: Line 320:
|
|
|-
|-
|
|
|
|
|
Line 292: Line 327:
|
|
|-
|-
|
|
|
|
|
Line 298: Line 334:
|
|
|-
|-
|
|
|
|
|
Line 310: Line 347:
|-
|-
| rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Autoimmune conditions]]
| rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Autoimmune conditions]]
|
|
|
|
|
Line 316: Line 354:
|
|
|-
|-
|
|
|
|
|
Line 322: Line 361:
|
|
|-
|-
|
|
|
|
|
Line 328: Line 368:
|
|
|-
|-
|
|
|
|
|
Line 338: Line 379:
|
|
|  
|  
|
|
|
|-
|-
|
|
|
|
|
Line 346: Line 389:
|
|
|-
|-
|
|
|
|
|
Line 353: Line 397:
|-
|-
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Idiopathic conditions]]
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vesicular/Ulcerative oral lesions|Idiopathic conditions]]
|
|
|
|
|
Line 359: Line 404:
|
|
|-
|-
|
|
|
|
|
Line 365: Line 411:
|
|
|-
|-
|
|
|
|
|
Line 371: Line 418:
|
|
|-
|-
|
|
|
|
|
Line 377: Line 425:
|
|
|-
|-
|
|
|
|
|

Revision as of 15:02, 11 February 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Muhammad Affan M.D.[2]

Surface oral lesions
Oral lesions Appearance Associated conditions Location Microscopic Image
White Lesions Leukoedema
  • White or whitish grey edematous lesion
  • Diffuse or patchy
  • Variant of normal oral mucosa
  • Buccal and labial oral mucosa
  • Intracellular edema or vacuolization of Malpighian cells
Fordyce granules
  • White or yellow discrete papules
  • Symmetrically distributed
  • Variant of normal oral mucosa
  • Buccal mucosa
  • Vermillion border of the lips
  • Similar to normal sebaceous glands of skin
  • Lacks hair follicles and almost always lack ductal communication with surface
Benign migratoy glossitis
  • Red patches with white distinct border
  • Map like appearance
  • Psoriasis
  • Diabetes
  • Reiter's syndrome
  • Medications such as Oral contraceptive pills and lithium carbonate
  • Dorsal/Lateral surface of the tongue
Hairy tongue
  • Elongated filliform lingual papillae
  • Carpet like appearance
  • Xerostomia
  • Medications such as anti-psychotics
  • HIV
  • Amyotropic lateral sclerosis
  • Dorsum of the tongue
Hairy leukoplakia

White patches

  • Corrugated in appearance
  • Hairy, hair-like growths
  • Permanent
  • Buccal mucosa
  • Lateral surface of the tongue
  • Floor of the mouth
  • Palate
White sponge nevus
  • White patches of tissue (nevi)
  • Singular or multiple
  • Thickened, velvety, sponge-like appearance
  • Heriditarary
  • Buccal mucosa
Lichen Planus
  • Reticular or papular lace like white lesions
  • Multiple, Painful
  • Autoimmune disorders disorders
  • Posterior buccal mucosa
  • Gingival margin
Frictional hyperkeratosis
  • White shaggy plaques
  • Could be easily peeled without any pain leaving normal mucosa
  • Bite trauma
  • Grinding of the teeth
  • Buccal mucosa
  • Limited to line of dental occlusion
Leukoplakia
  • White or grayish in patches that can't be wiped away
  • Irregular or flat-textured
  • Thickened or hardened in areas
  • Along with raised, red lesions (speckled leukoplakia or erythroplakia), which are more likely to show precancerous changes
  • Smoking
Erythroplakia
  • Fiery red patch
    • Smooth, velvety, granular or nodular lesions
  • Highest risk of malignant transformation
  • Soft palate
  • Floor of mouth
  • Ventral surface of tongue and the retromolar area
Pigmented lesions Characterestic features Associated conditions Location Image
  • Physiologic pigmentation
  • Ephelis
  • Oral melanocytic macule
  • Melanocytic nevus
  • Oral melanoacanthoma
  • Smoker's melanosis
  • Melanoma
  • Kaposi sarcoma
  • Addison's disease
  • Peutz jeghers syndrome
  • Neurofibromatosis
  • Polyostotic fibrous dysplasia
  • Medication induced pigmentation
  • Amalgam tattoo
Vesicular/Ulcerative oral lesions Symptoms characterestic features Associated conditions Location Image
Infections
Autoimmune conditions
Idiopathic conditions
Soft tissue oral lesions
Reactive lesions Symptoms Characterstic features Associated conditions Location Image
  • Leukoedema
  • Fordyce granules
  • Hairy tongue
  • Hairy leukoplakia
  • White sponge nevus
  • Lichen planus
  • Focal keratosis
Tumors etiology location Clinical appearance Gold standard/Diagnosis Image
Benign tumors
  • Epithelial tumors
  • Mesenchymal tumors
  • Salivary gland tumors
Malignant tumors
Cysts
  • Gingival cyst
  • Lymphoepithelial cyst
  • Epidermoid cyst
  • Thyroglossal tract cyst
  • Nasolabial cyst

References